cushieblog.com
Osilodrostat maintained cortisol control in Cushing’s syndrome
Osilodrostat, a drug that normalized cortisol in 89% of patients with Cushing’s syndrome who took it during a phase II study, continued to exert a sustained benefit during a 31-month extension phas…